
### [NCIT:C3027](http://purl.obolibrary.org/obo/NCIT_C3027)
**Label:** Esophageal Disorder

**Subclasses:** [NCIT:C3027](http://purl.obolibrary.org/obo/NCIT_C3027) (Esophageal Disorder), [NCIT:C3866](http://purl.obolibrary.org/obo/NCIT_C3866) (Esophageal Leiomyoma), [NCIT:C5687](http://purl.obolibrary.org/obo/NCIT_C5687) (Esophageal Lymphoma), [NCIT:C5688](http://purl.obolibrary.org/obo/NCIT_C5688) (Esophageal Non-Hodgkin Lymphoma), [NCIT:C5689](http://purl.obolibrary.org/obo/NCIT_C5689) (Esophageal Hodgkin Lymphoma), [NCIT:C3028](http://purl.obolibrary.org/obo/NCIT_C3028) (Esophageal Neoplasm), [NCIT:C95620](http://purl.obolibrary.org/obo/NCIT_C95620) (Esophageal Large Cell Neuroendocrine Carcinoma), [NCIT:C8632](http://purl.obolibrary.org/obo/NCIT_C8632) (Stage IV Esophageal Adenocarcinoma AJCC v7), [NCIT:C8633](http://purl.obolibrary.org/obo/NCIT_C8633) (Recurrent Esophageal Squamous Cell Carcinoma), [NCIT:C7027](http://purl.obolibrary.org/obo/NCIT_C7027) (Barrett Adenocarcinoma), [NCIT:C8630](http://purl.obolibrary.org/obo/NCIT_C8630) (Stage I Esophageal Adenocarcinoma AJCC v7), [NCIT:C7423](http://purl.obolibrary.org/obo/NCIT_C7423) (Esophageal Precancerous Condition), [NCIT:C8631](http://purl.obolibrary.org/obo/NCIT_C8631) (Stage III Esophageal Adenocarcinoma AJCC v7), [NCIT:C2891](http://purl.obolibrary.org/obo/NCIT_C2891) (Barrett Esophagus), [NCIT:C95626](http://purl.obolibrary.org/obo/NCIT_C95626) (Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C95625](http://purl.obolibrary.org/obo/NCIT_C95625) (Esophageal Diffuse Large B-Cell Lymphoma), [NCIT:C95623](http://purl.obolibrary.org/obo/NCIT_C95623) (Esophageal Rhabdomyosarcoma), [NCIT:C91221](http://purl.obolibrary.org/obo/NCIT_C91221) (Esophageal Cancer by AJCC v7 Stage), [NCIT:C95622](http://purl.obolibrary.org/obo/NCIT_C95622) (Esophageal Hemangioma), [NCIT:C95621](http://purl.obolibrary.org/obo/NCIT_C95621) (Esophageal Mixed Adenoneuroendocrine Carcinoma), [NCIT:C89771](http://purl.obolibrary.org/obo/NCIT_C89771) (Stage 0 Esophageal Cancer AJCC v7), [NCIT:C4839](http://purl.obolibrary.org/obo/NCIT_C4839) (Esophageal Intraepithelial Neoplasia), [NCIT:C5019](http://purl.obolibrary.org/obo/NCIT_C5019) (Stage IV Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C3598](http://purl.obolibrary.org/obo/NCIT_C3598) (Benign Esophageal Neoplasm), [NCIT:C3999](http://purl.obolibrary.org/obo/NCIT_C3999) (Recurrent Esophageal Carcinoma), [NCIT:C5334](http://purl.obolibrary.org/obo/NCIT_C5334) (Esophageal Leiomyosarcoma), [NCIT:C7479](http://purl.obolibrary.org/obo/NCIT_C7479) (Metastatic Malignant Neoplasm in the Esophagus), [NCIT:C4840](http://purl.obolibrary.org/obo/NCIT_C4840) (Esophageal Low Grade Intraepithelial Neoplasia), [NCIT:C133411](http://purl.obolibrary.org/obo/NCIT_C133411) (Esophageal Adenocarcinoma by AJCC v7 Stage), [NCIT:C3513](http://purl.obolibrary.org/obo/NCIT_C3513) (Esophageal Carcinoma), [NCIT:C89804](http://purl.obolibrary.org/obo/NCIT_C89804) (Stage IV Esophageal Cancer AJCC v7), [NCIT:C7478](http://purl.obolibrary.org/obo/NCIT_C7478) (Malignant Esophageal Neoplasm), [NCIT:C9213](http://purl.obolibrary.org/obo/NCIT_C9213) (Stage IV Esophageal Cancer AJCC v6), [NCIT:C9211](http://purl.obolibrary.org/obo/NCIT_C9211) (Stage II Esophageal Cancer AJCC v6), [NCIT:C9212](http://purl.obolibrary.org/obo/NCIT_C9212) (Stage III Esophageal Cancer AJCC v6), [NCIT:C9210](http://purl.obolibrary.org/obo/NCIT_C9210) (Stage I Esophageal Cancer AJCC v6), [NCIT:C90500](http://purl.obolibrary.org/obo/NCIT_C90500) (Esophageal Cancer by AJCC v6 Stage), [NCIT:C27928](http://purl.obolibrary.org/obo/NCIT_C27928) (Alcohol-Related Esophageal Squamous Cell Carcinoma), [NCIT:C3637](http://purl.obolibrary.org/obo/NCIT_C3637) (Stage 0 Esophageal Cancer AJCC v6), [NCIT:C5701](http://purl.obolibrary.org/obo/NCIT_C5701) (Esophageal Lipoma), [NCIT:C133442](http://purl.obolibrary.org/obo/NCIT_C133442) (Esophageal Squamous Cell Carcinoma by AJCC v7 Stage), [NCIT:C5702](http://purl.obolibrary.org/obo/NCIT_C5702) (Esophageal Fibroma), [NCIT:C133443](http://purl.obolibrary.org/obo/NCIT_C133443) (Esophageal Squamous Cell Carcinoma by AJCC v8 Stage), [NCIT:C5704](http://purl.obolibrary.org/obo/NCIT_C5704) (Esophageal Neurofibroma), [NCIT:C133400](http://purl.obolibrary.org/obo/NCIT_C133400) (Esophageal Adenocarcinoma by AJCC v8 Stage), [NCIT:C27430](http://purl.obolibrary.org/obo/NCIT_C27430) (Esophageal Gastrointestinal Stromal Tumor), [NCIT:C5820](http://purl.obolibrary.org/obo/NCIT_C5820) (Esophageal Neuroendocrine Tumor G1), [NCIT:C26781](http://purl.obolibrary.org/obo/NCIT_C26781) (Gastroesophageal Reflux Disease), [NCIT:C5700](http://purl.obolibrary.org/obo/NCIT_C5700) (Esophageal Granular Cell Tumor), [NCIT:C5821](http://purl.obolibrary.org/obo/NCIT_C5821) (Esophageal Neuroendocrine Neoplasm), [NCIT:C5022](http://purl.obolibrary.org/obo/NCIT_C5022) (Stage I Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5341](http://purl.obolibrary.org/obo/NCIT_C5341) (Esophageal Sarcoma), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5342](http://purl.obolibrary.org/obo/NCIT_C5342) (Esophageal Adenoid Cystic Carcinoma), [NCIT:C5343](http://purl.obolibrary.org/obo/NCIT_C5343) (Esophageal Mucoepidermoid Carcinoma), [NCIT:C9224](http://purl.obolibrary.org/obo/NCIT_C9224) (Esophagitis), [NCIT:C5344](http://purl.obolibrary.org/obo/NCIT_C5344) (Esophageal Squamous Papilloma), [NCIT:C4057](http://purl.obolibrary.org/obo/NCIT_C4057) (Esophageal Polyp), [NCIT:C5020](http://purl.obolibrary.org/obo/NCIT_C5020) (Stage III Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C5021](http://purl.obolibrary.org/obo/NCIT_C5021) (Stage II Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C89795](http://purl.obolibrary.org/obo/NCIT_C89795) (Stage III Esophageal Cancer AJCC v7), [NCIT:C89794](http://purl.obolibrary.org/obo/NCIT_C89794) (Stage II Esophageal Cancer AJCC v7), [NCIT:C5705](http://purl.obolibrary.org/obo/NCIT_C5705) (Esophageal Liposarcoma), [NCIT:C89793](http://purl.obolibrary.org/obo/NCIT_C89793) (Stage I Esophageal Cancer AJCC v7), [NCIT:C5706](http://purl.obolibrary.org/obo/NCIT_C5706) (Esophageal Kaposi Sarcoma), [NCIT:C95608](http://purl.obolibrary.org/obo/NCIT_C95608) (Esophageal Spindle Cell Carcinoma), [NCIT:C5707](http://purl.obolibrary.org/obo/NCIT_C5707) (Esophageal Melanoma), [NCIT:C27421](http://purl.obolibrary.org/obo/NCIT_C27421) (Esophageal Adenosquamous Carcinoma), [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C133399](http://purl.obolibrary.org/obo/NCIT_C133399) (Esophageal Cancer by AJCC v8 Stage), [NCIT:C27423](http://purl.obolibrary.org/obo/NCIT_C27423) (Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C8627](http://purl.obolibrary.org/obo/NCIT_C8627) (Recurrent Esophageal Adenocarcinoma), [NCIT:C27422](http://purl.obolibrary.org/obo/NCIT_C27422) (Esophageal Undifferentiated Carcinoma), [NCIT:C8628](http://purl.obolibrary.org/obo/NCIT_C8628) (Stage II Esophageal Adenocarcinoma AJCC v7), [NCIT:C4025](http://purl.obolibrary.org/obo/NCIT_C4025) (Esophageal Adenocarcinoma), [NCIT:C53497](http://purl.obolibrary.org/obo/NCIT_C53497) (Non-Neoplastic Esophageal Disorder), [NCIT:C27429](http://purl.obolibrary.org/obo/NCIT_C27429) (High Grade Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C27428](http://purl.obolibrary.org/obo/NCIT_C27428) (Low Grade Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C92185](http://purl.obolibrary.org/obo/NCIT_C92185) (Malignant Esophageal Peripheral Nerve Sheath Tumor), [NCIT:C6762](http://purl.obolibrary.org/obo/NCIT_C6762) (Esophageal Small Cell Neuroendocrine Carcinoma), [NCIT:C4024](http://purl.obolibrary.org/obo/NCIT_C4024) (Esophageal Squamous Cell Carcinoma), [NCIT:C27425](http://purl.obolibrary.org/obo/NCIT_C27425) (Esophageal High Grade Intraepithelial Neoplasia), [NCIT:C27424](http://purl.obolibrary.org/obo/NCIT_C27424) (Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C27427](http://purl.obolibrary.org/obo/NCIT_C27427) (Low Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C27426](http://purl.obolibrary.org/obo/NCIT_C27426) (High Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C95617](http://purl.obolibrary.org/obo/NCIT_C95617) (Esophageal Neuroendocrine Tumor G2), [NCIT:C95616](http://purl.obolibrary.org/obo/NCIT_C95616) (Esophageal Neuroendocrine Tumor), [NCIT:C95613](http://purl.obolibrary.org/obo/NCIT_C95613) (Intraepithelial Neoplasia in Barrett Esophagus), [NCIT:C95612](http://purl.obolibrary.org/obo/NCIT_C95612) (Esophageal Poorly Differentiated Squamous Cell Carcinoma), [NCIT:C95611](http://purl.obolibrary.org/obo/NCIT_C95611) (Esophageal Moderately Differentiated Squamous Cell Carcinoma), [NCIT:C95610](http://purl.obolibrary.org/obo/NCIT_C95610) (Esophageal Well Differentiated Squamous Cell Carcinoma), [NCIT:C118812](http://purl.obolibrary.org/obo/NCIT_C118812) (Childhood Esophageal Carcinoma), [NCIT:C95619](http://purl.obolibrary.org/obo/NCIT_C95619) (Esophageal Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C3027](http://purl.obolibrary.org/obo/NCIT_C3027) (Esophageal Disorder) 99.47%
- [NCIT:C3028](http://purl.obolibrary.org/obo/NCIT_C3028) (Esophageal Neoplasm) 96.28%
- [NCIT:C7478](http://purl.obolibrary.org/obo/NCIT_C7478) (Malignant Esophageal Neoplasm) 82.98%
- [NCIT:C3513](http://purl.obolibrary.org/obo/NCIT_C3513) (Esophageal Carcinoma) 75.53%
- [NCIT:C2990](http://purl.obolibrary.org/obo/NCIT_C2990) (Digestive System Disorder) 63.32%
- [NCIT:C3052](http://purl.obolibrary.org/obo/NCIT_C3052) (Digestive System Neoplasm) 60.10%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 55.58%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 55.39%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 55.38%
- Thing 54.22%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 52.36%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 52.16%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 48.25%
- [NCIT:C4890](http://purl.obolibrary.org/obo/NCIT_C4890) (Malignant Digestive System Neoplasm) 47.54%
- [NCIT:C96963](http://purl.obolibrary.org/obo/NCIT_C96963) (Digestive System Carcinoma) 40.16%


